At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Manager, Market Access
Major Duties & Responsibilities
* The Market Access manager in Korea is responsible for developing and executing reimbursement and pricing strategies that deliver optimal market access for a portfolio of innovative medicines of Bristol-Myers Squibb.
The position reports to
* the VAP & HEOR (Value, Access, Pricing & Health economic outcome research) Lead of Korea.
Key Area of Responsibilities
* Develop and implement market access strategy including evidence generation plan with understanding products, markets, customers, healthcare policy and procedural rules and regulations related to price and reimbursement approval
* Actively identify and provide analysis of the access opportunities and challenges to the VAP&HEOR Lead and relevant internal stakeholders ; take responsibility for and actively participate in the development of access plans to reach best impact from cross-functional collaboration.
* Prepare P&R dossier and manage external stakeholder(HIRA, NHIS, MOHW etc) for reimbursement and negotiation
* Actively participate in market access environment shaping and advocacy initiatives through industry network to keep abreast of policy changes and development of market environment
* Provide inputs to business decisions appropriately based on assessment and analysis of expected negative or positive impacts
* Develop HEOR plan and organize HEOR studies which are aligned with access objectives.
Desired Experience & Qualification
* Bachelor or above degree. Degree/Masters in Economics, Health Economics, Public Policy or other related field is preferred.
* Minimum 7 year-experience in pharmaceutical and/or healthcare industry
* Excellent understanding of the Korean healthcare systems, process/ concepts and pricing dynamics for pharmaceutical medicines
* Demonstrated ability in value-based communication and clear focus for influencing and negotiating with access stakeholders
* A strong operational focus, team-orientation and a collaboration spirit
* Ability to generate innovative ideas/solutions
* Fluent in English written/oral
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
Summit, NJ
Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE to treat breast, non-small cell lung, pancreatic, and gastric cancers.
The company’s products also include IDHIFA for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (rrAML) with an isocitrate dehydrogenase-2 mutation; VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; THALOMID to treat patients with MM; and ISTODAX, an epigenetic modifier. Its preclinical and clinical-stage product candidates include small molecules, biologics, and cell therapies for immune-inflammatory diseases, myeloid diseases, epigenetics, protein homeostasis, and immuno-oncology.
The company has agreements with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; bluebird bio, Inc.; Lycera Corp.; Juno Therapeutics, Inc.; EXSCIENTIA LTD.; and IMIDomics SL, as well as immuno-oncology collaboration with Sutro Biopharma. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.